Carbapenem-resistant Gram-negative pathogens in a German university medical center: Prevalence, clinical implications and the role of novel β-lactam/β-lactamase inhibitor combinations-Reference-Cited by-同舟云学术

Carbapenem-resistant Gram-negative pathogens in a German university medical center: Prevalence, clinical implications and the role of novel β-lactam/β-lactamase inhibitor combinations

Published:2018-04-12 Issue:4 Volume:13 Page:e0195757
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Katchanov Juri,Asar Lucia,Klupp Eva-Maria,Both Anna,Rothe Camilla,König Christina,Rohde Holger,Kluge Stefan,Maurer Florian P.^ORCID

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference37 articles.

1. Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study;H Grundmann;Lancet Infect Dis,2017

2. Treatment options for infections caused by carbapenem-resistant Enterobacteriaceae: can we apply “precision medicine” to antimicrobial chemotherapy?;F Perez;Expert Opin Pharmacother,2016

3. Antibiotic treatment of infections due to carbapenem-resistant Enterobacteriaceae: systematic evaluation of the available evidence;ME Falagas;Antimicrob Agents Chemother,2014

4. Activity of ceftolozane/tazobactam against surveillance and “problem” Enterobacteriaceae, Pseudomonas aeruginosa and non-fermenters from the British Isles;DM Livermore;J Antimicrob Chemother,2017

5. Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed;Y Carmeli;Lancet Infect Dis,2016

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of Ceftazidime-Avibactam Susceptibility in Multidrug Resistant Gram Negative Bacteria;ANKEM Dergisi;2023-12-31

2. Rapid development of cefiderocol resistance in a carbapenem-resistant Pseudomonas aeruginosa isolate associated with mutations in the pyoverdine biosynthesis pathway;Journal of Global Antimicrobial Resistance;2023-09

3. Molecular epidemiology, risk factors, and outcomes of carbapenem-resistant Klebsiella pneumoniae infection in a tertiary hospital in eastern China: for a retrospective study conducted over 4 years;Frontiers in Microbiology;2023-07-27

4. Clinical and Molecular Profile of Carbapenem Resistant Klebsiella pneumoniae Infections in a Tertiary Care Hospital –Mangalore;Infection and Drug Resistance;2023-07

5. Extended and Continuous Infusion of Novel Protected β-Lactam Antibiotics: A Narrative Review;Drugs;2023-06-14